For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) closed at $14.29 in the last session, up 11.21% from day before closing price of $12.85. In other words, the price has increased by $11.21 from its previous closing price. On the day, 1.5 million shares were traded.
Ratios:
We take a closer look at DNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 5.79. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.56.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 04 ’25 when Dmytruk Mark E. bought 740 shares for $13.44 per share.
Che Austin bought 99 shares of DNA for $1,316 on Feb 04 ’25. On Feb 03 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $12.37 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.77 while its Price-to-Book (P/B) ratio in mrq is 0.90.
Stock Price History:
Over the past 52 weeks, DNA has reached a high of $64.40, while it has fallen to a 52-week low of $5.26. The 50-Day Moving Average of the stock is 38.58%, while the 200-Day Moving Average is calculated to be 2.80%.
Shares Statistics:
A total of 41.37M shares are outstanding, with a floating share count of 36.49M. Insiders hold about 33.02% of the company’s shares, while institutions hold 47.45% stake in the company.
